Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal nalbuphine added to hyperbaric bupivacaine for postoperative pain after anorectal surgery
ACTRN12624000527561Phase 4Recruiting
- Sponsor
- Nantapat Soonthonnitikul
- Start
- Sep 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Intrathecal bupivacaine + nalbuphine with Intrathecal bupivacaine alone (2 arms). Primary endpoints: Postoperative pain score at rest and Postoperative pain score on motion. Started Sep 2023; status: recruiting.
02
Drugs
nalbuphinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12624000527561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000527561.